Transgenomic (TBIO) Tops Q4 EPS by 13c
Tweet
Share
E-mail
Get Alerts TBIO Hot Sheet
Price: $3.23 --0%
Financial Fact:
Research and development: 393K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 393K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Transgenomic (NASDAQ: TBIO) reported Q4 EPS of ($0.28), $0.13 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $7.2 million.
For earnings history and earnings-related data on Transgenomic (TBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
